USANA Health Sciences (NYSE:USNA – Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, February 4th. Analysts expect USANA Health Sciences to post earnings of $0.49 per share and revenue of $208,840.00 billion for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
USANA Health Sciences Price Performance
USNA opened at $34.37 on Tuesday. The firm has a market cap of $655.04 million, a PE ratio of 12.14, a P/E/G ratio of 0.92 and a beta of 0.89. The stock has a 50-day moving average price of $36.32 and a 200-day moving average price of $38.33. USANA Health Sciences has a 1 year low of $31.44 and a 1 year high of $52.75.
Insiders Place Their Bets
In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
- Five stocks we like better than USANA Health Sciences
- What Are the FAANG Stocks and Are They Good Investments?
- Sizing Up a New Opportunity for NVIDIA Investors
- 3 Warren Buffett Stocks to Buy Now
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- 3 Best Fintech Stocks for a Portfolio Boost
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.